ALGERNON PHARMACEUTICALS INC. as the Corporation and AST TRUST COMPANY (CANADA) as the Warrant AgentIndenture • January 21st, 2022 • Algernon Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
Contract Type FiledJanuary 21st, 2022 Company Industry JurisdictionWe have read the foregoing representations of our customer,_____________________________________ (the "Seller") with regard to the sale, for such Seller's account, of Class A common shares (the "Shares") of the Corporation represented by certificate number or held in Direct Registration System (DRS) account number . We have executed sales of the Securities pursuant to Rule 904 of Regulation S under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), on behalf of the Seller. In that connection, we hereby represent to you as follows:
ALGERNON PHARMACEUTICALS INC. as the Corporation and AST TRUST COMPANY (CANADA) as the Warrant AgentIndenture • January 21st, 2022 • Algernon Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
Contract Type FiledJanuary 21st, 2022 Company Industry JurisdictionWe have read the foregoing representations of our customer,_____________________________________(the "Seller") with regard to the sale, for such Seller's account, of Class A common shares (the "Shares") of the Corporation represented by certificate number or held in Direct Registration System (DRS) account number . We have executed sales of the Securities pursuant to Rule 904 of Regulation S under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), on behalf of the Seller. In that connection, we hereby represent to you as follows: